TheraRadar
Data updated: May 26, 2026

CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE (betamethasone dipropionate)

Immunology Approved 2020-09-11
Jump to: Indications Approvals Trials Competitors Safety Patents
1
Indication
--
Phase 3 Trials
5
Years on Market

Details

Status
Discontinued
First Approved
2020-09-11
Routes
TOPICAL
Dosage Forms
SUSPENSION

Companies

PADAGIS ISRAEL
Active Ingredient: BETAMETHASONE DIPROPIONATE , CALCIPOTRIENE

CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE Approval History

2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
1 FDA actions from 2020 to 2020
Sep 2020 ORIGINAL
Update

What CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE Treats

1 FDA approvals

Originally approved for its first indication in 2020 .

  • Other (1)
📋

Clinical Trial Registry

1 trials
Trial Sponsor ID Phase Status Title
NCT06332612 MROSF 8420224AROM Ph 1, Ph 2 completed Metformin Repurposing in Oral Submucous Fibrosis: Unveiling In Vitro Signaling Pathways, Progressing to Clinical Trial
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE FDA Label Details

Track CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

FDA Approval: ANDA212367 → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.